The fasting hyperglycaemia study: I. Subject identification and recruitment for a non-insulin-dependent diabetes prevention trial

Metabolism: Clinical and Experimental

Volumn 46, Issue SUPPL.1, 1997, Pages 44-49

  Hammersley, M S ^b   Meyer, L C ^b   Morris, R J ^b   Manley, S E ^b   Turner, R C ^b   Holman, R R ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLICLAZIDE; GLUCOSE; SULFONYLUREA DERIVATIVE;

ADULT; ANAMNESIS; ARTICLE; CLINICAL TRIAL; DIET RESTRICTION; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSURIA; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PATIENT SELECTION; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; ENGLAND; FASTING; FEMALE; FRANCE; FRUCTOSAMINE; GLICLAZIDE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INTERVENTION STUDIES; LIFE STYLE; MALE; MIDDLE AGED; PATIENT SELECTION; RISK FACTORS; SULFONYLUREA COMPOUNDS; TIME FACTORS; WORLD HEALTH ORGANIZATION;

EID: 0031432139     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90317-6     Document Type: Article

References (26)

1. UK Prospective Diabetes Study Group: UK Prospective Diabetes Study VIII: Study design, progress and performance. Diabetologia 34:877-890, 1991
2. Jarrett RI, Keen H, McCartney P: The Whitehall Study: Ten year follow-up report on men with impaired glucose tolerance with reference to worsening to diabetes and predictors of death. Diabet Med 1:279-283, 1984
3. Eschwège E, Richard JL, Thibult N, et al: Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later. Horm Metab Res Suppl 15:41-46, 1985
4. Pan W-H, Cedres LB, Liu K, et al: Relationship of clinical diabetes and symptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 123:504-516, 1986
5. Perry IJ, Wannamethee G, Whincup PH, et al: Asymptomatic hyperglycaemia and major ischaemic heart disease events in Britain. J Epidemiol Community Health 48:538-542, 1994
6. McPhillips JB, Barrett-Connor E, Wingard DL: Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. Am J Epidemiol 131:443-453, 1990
7. McDonald GW, Fisher GF, Burnham C: Reproducibility of the oral glucose tolerance test. Diabetes 14:473-480, 1965
8. Riccardi G, Vaccaro O, Rivelles A, et al: Reproducibility of the new diagnostic criteria for impaired glucose tolerance. Am J Epidemiol 212:422-429, 1985
9. Holman RR, Turner RC: The basal plasma glucose: A simple relevant index of diabetes. Clin Endocrinol (Oxf) 14:279-286, 1981
10. World Health Organization: Diabetes mellitus. World Health Organ Tech Rep Ser 727, 1985
11. Fasting Hyperglycaemia Study Group: The Fasting Hyperglycaemia Study: II. Randomized controlled trial of reinforced healthy living advice in subjects with increased but not diabetic fasting plasma glucose. Metabolism 46:50-55, 1997 (suppl 1)
12. Fasting Hyperglycaemia Study Group: The Fasting Hyperglycaemia Study: III. Randomized controlled trial of sulfonylurea therapy in subjects with increased but not diabetic fasting plasma glucose. Metabolism 46:56-60, 1997 (suppl 1)
13. UK Prospective Diabetes Study Group: UK Prospective Diabetes Study XI: Biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects. Diabet Med 11:534-544, 1994
14. SAS Institute: Statistical Analysis System (ed 6). Cary, NC, SAS Institute, 1990
15. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
16. UK Prospective Diabetes Study Group: UK Prospective Diabetes Study XVI: Overview of six years' therapy of type 2 diabetes - A progressive disease. Diabetes 44:1249-1258, 1995
17. Krolewski AS, Laffel LM, Krolewski M, et al: Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 332:1251-1255, 1995
18. Alberti KGMM: The clinical implications of impaired glucose tolerance. Diabet Med 13:927-937, 1996
19. Kadowaki T, Miyake Y, Hagura R, et al: Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia 26:44-49, 1984
20. Cook JT, Page RC, Levy JC, et al: Hyperglycaemic progression in subjects with impaired glucose tolerance: Association with decline in beta cell function. Diabet Med 10:321-326, 1993
21. Harris MI: Impaired glucose tolerance in the US population. Diabetes Care 12:464-474, 1993
22. Harris MI, Hadden WC, Knowler WC, et al: Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20-74. Diabetes 36:523-534, 1987
23. Welborn TA, Glatthaar C, Whittall D, et al: An estimate of diabetes prevalence from a national population sample: A male excess. Med J Aust 150:78-81, 1989
24. Philipps K, Barker DJ, Hales CN, et al: Fetal growth and impaired glucose tolerance in men and women. Diabetologia 36:225-228, 1993
25. McCance DR, Pettit DJ, Hanson RL, et al: Birth weight and non-insulin dependent diabetes: Thrifty genotype, thrifty phenotype, or surviving small baby genotype? Br Med J 308:942-945, 1994
26. Samanta A, Burden AC, Fent B: Comparative prevalence of non-insulin dependent diabetes mellitus in Asian and white Caucasian adults. Diabetes Res Clin Pract 4:1-6, 1987